SeekIn
SeekIn Inc. is a biotech company founded in 2017 specializing in blood-based pan-cancer early detection using next-generation sequencing and artificial intelligence. The company develops cost-effective, non-invasive blood tests for early cancer detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn has also created molecular tests for leukemia and applied its technology to canines. It collaborates with top hospitals in Europe and China and aims to reduce cancer mortality by 15% through early detection. Its management team combines expertise in R&D, clinical lab management, business operations, finance, and commercialization. Key products include OncoSeek, SeekInCare, SeekInCure, SeekInClarity, LeukoPrint, and PanCanSeek, offering multiplex, stepwise cancer screening and monitoring solutions.
SeekIn
SeekIn Inc. is a biotech company founded in 2017 specializing in blood-based pan-cancer early detection using next-generation sequencing and artificial intelligence. The company develops cost-effective, non-invasive blood tests for early cancer detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn has also created molecular tests for leukemia and applied its technology to canines. It collaborates with top hospitals in Europe and China and aims to reduce cancer mortality by 15% through early detection. Its management team combines expertise in R&D, clinical lab management, business operations, finance, and commercialization. Key products include OncoSeek, SeekInCare, SeekInCure, SeekInClarity, LeukoPrint, and PanCanSeek, offering multiplex, stepwise cancer screening and monitoring solutions.